Author

JM Hubbard

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5082234818

Abstract P6-21-03: Phase I trial of intratumoral (IT) administration of a NIS-expressing derivative manufactured from a genetically engineered strain of measles virus (MV)

2019 · MC Liu, K-W Peng, et al. · Cancer Research · 6

Works count: 1

Citation count: 6

H-index: 1

I10-index: